<DrugInformationSummary id="CDR0000537382"><DrugInfoMetaData><DrugInfoType>Brief</DrugInfoType><DrugInfoAudience>Patients</DrugInfoAudience><DrugInfoDescription>Irinotecan hydrochloride is a type of chemotherapy drug called a topoisomerase I inhibitor. It causes breaks that cannot be repaired in the DNA of cells. This stops the growth of cancer cells and other rapidly dividing cells and causes them to die.</DrugInfoDescription><DrugInfoURL xref="https://www.cancer.gov/about-cancer/treatment/drugs/irinotecanhydrochloride">Irinotecan Hydrochloride</DrugInfoURL><FDAApproved>Yes</FDAApproved><TerminologyLink ref="CDR0000041714">irinotecan hydrochloride</TerminologyLink><GlossaryLink ref="CDR0000635811">irinotecan hydrochloride</GlossaryLink><USBrandNames><USBrandName>Camptosar</USBrandName></USBrandNames><PronunciationInfo><TermPronunciation>I-rih-noh-TEE-kan HY-droh-KLOR-ide</TermPronunciation><MediaLink ref="CDR0000722885" type="audio/mpeg" alt="" language="en" id="_3"/><MediaLink ref="CDR0000722886" type="audio/mpeg" alt="" language="es" id="_4"/></PronunciationInfo><FDAExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=IRINOTECAN+HYDROCHLORIDE&amp;pagesize=20&amp;page=1&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</FDAExternalRef></DrugInfoMetaData><DrugInfoTitle>Irinotecan Hydrochloride</DrugInfoTitle><Section id="_FDA"><Para><ExternalRef xref="https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&amp;query=IRINOTECAN+HYDROCHLORIDE&amp;pagesize=20&amp;page=1&amp;audience=consumer">FDA label information for this drug is available at DailyMed.</ExternalRef></Para></Section><Section id="_1"><Title>Use in Cancer</Title>                                                              
  <Para id="_2">Irinotecan hydrochloride is approved to be used alone or with other   drugs to treat:</Para><ItemizedList Style="bullet" id="_5"><ListItem><Strong><GlossaryTermRef href="CDR0000444983" dictionary="Cancer.gov" audience="Patient">Colorectal cancer</GlossaryTermRef></Strong> that has <GlossaryTermRef href="CDR0000046283" dictionary="Cancer.gov" audience="Patient">metastasized</GlossaryTermRef> (spread to other parts of the body), including metastatic cancer that has  <GlossaryTermRef href="CDR0000045862" dictionary="Cancer.gov" audience="Patient">recurred</GlossaryTermRef> (come back) or has not gotten better with other <GlossaryTermRef href="CDR0000045214" dictionary="Cancer.gov" audience="Patient">chemotherapy</GlossaryTermRef>.</ListItem></ItemizedList><Para id="_3">Irinotecan hydrochloride is also being studied in the treatment of other types of cancer. </Para>                          
 <Para id="_11">Irinotecan hydrochloride is also available  in a different form called <GlossaryTermRef href="CDR0000776570" dictionary="Cancer.gov" audience="Patient">irinotecan sucrosofate</GlossaryTermRef>. For more information, see the Drug Information Summary for <DrugRef href="CDR0000776561" url="/about-cancer/treatment/drugs/irinotecan-hydrochloride-liposome">Irinotecan Sucrosofate</DrugRef>.</Para></Section><Section id="_About"><Title>More About Irinotecan Hydrochloride</Title><Para id="_Dict_1"><ExternalRef xref="https://www.cancer.gov/publications/dictionaries/cancer-drug/def/41714">Definition from the NCI Drug Dictionary</ExternalRef> - Detailed scientific definition and other names for this drug.</Para>

<Para id="_About_8.5">MedlinePlus Information on <ExternalRef xref="https://medlineplus.gov/druginfo/meds/a608043.html">Irinotecan Hydrochloride</ExternalRef> - A lay language summary of important information about this drug that may include the following:</Para>
<ItemizedList Style="bullet" id="_About_9.6"><ListItem>warnings about this drug,</ListItem><ListItem>what this drug is used for and how it is used,</ListItem><ListItem>what you should tell your doctor before using this drug,</ListItem><ListItem>what you should know about this drug before using it, </ListItem><ListItem>other drugs that may interact with this drug, and</ListItem><ListItem>possible side effects.  </ListItem></ItemizedList><Para id="_About_10.7">Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for.  This patient information sheet applies only to approved uses of the drug.  However, much of the information may also apply to unapproved uses that are being studied.</Para></Section><Section id="_ClinicalTrial_1"><Title>Clinical Trials Accepting Patients</Title><Para id="_ClinicalTrial_2"><ExternalRef xref="https://www.cancer.gov/research/participate/clinical-trials/intervention/C1381">Find Clinical Trials for Irinotecan Hydrochloride</ExternalRef> - Check for trials from NCI's list of cancer clinical trials now accepting patients.</Para></Section> 
  <DrugInfoDisclaimer>


<Para id="_Disclaimer_4"><Strong>Important: </Strong>The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.
</Para></DrugInfoDisclaimer> 
  <DateFirstPublished>2007-04-20</DateFirstPublished><DateLastModified>2024-02-16</DateLastModified></DrugInformationSummary>
